WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010137027) SOLID ORAL DOSAGE FORMS OF LAMIVUDINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/137027    International Application No.:    PCT/IN2009/000305
Publication Date: 02.12.2010 International Filing Date: 27.05.2009
IPC:
A61K 31/7068 (2006.01), A61K 47/26 (2006.01)
Applicants: HETERO RESEARCH FOUNDATION [IN/IN]; Plot No. B-80 & 81, A.P.I.E. Balanagar Hyderabad Andhrapradesh Hyderabad 500 018 (IN) (For All Designated States Except US).
PARTHASARADHI REDDY, Bandi [IN/IN]; (IN) (For US Only).
SRINIVAS REDDY, Male [IN/IN]; (IN) (For US Only).
VENKATESWAR REDDY, PothireddY [IN/IN]; (IN) (For US Only).
VANAJA KUMARI, Muppidi [IN/IN]; (IN) (For US Only)
Inventors: PARTHASARADHI REDDY, Bandi; (IN).
SRINIVAS REDDY, Male; (IN).
VENKATESWAR REDDY, PothireddY; (IN).
VANAJA KUMARI, Muppidi; (IN)
Priority Data:
Title (EN) SOLID ORAL DOSAGE FORMS OF LAMIVUDINE
(FR) FORMES PHARMACEUTIQUES SOLIDES DE LAMIVUDINE S'ADMINISTRANT PAR VOIE ORALE
Abstract: front page image
(EN)The present invention relates to the oral solid pharmaceutical composition comprising lamivudine or a pharmaceutically acceptable salt thereof with isomalt as a filler. The present invention also relate to the combination of lamivudine and other Anti-HIV agents. Thus, for example, the present invention provides a stable tablet formulation comprising lamivudine, isomalt, crospovidone, calcium stearate and opadry white.
(FR)L'invention concerne une composition pharmaceutique solide s'administrant par voie orale qui comprend de la lamivudine ou un sel pharmaceutiquement acceptable de ce composé, et de l'isomalt comme matière de charge. L'invention concerne aussi la combinaison de lamivudine et d'autres agents anti-VIH. L'invention concerne une formulation de comprimé stable comprenant de la lamivudine, de l'isomalt, de la crospovidone, du stéarate de calcium et de l'opadry blanc.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)